Researchers supported by the National Institutes of Health have found that dual bronchodilators - long-lasting inhalers that relax the airways and make it easier to breathe - do little to help people ...

Please provide your email address to receive an email when new articles are posted on . Inhaled dual bronchodilator therapy did not decrease respiratory symptoms among individuals who were current or ...

Fixed long-acting combinations of both anticholinergic and beta-agonist bronchodilators, not previously available, have been developed. A new fixed combination of glycopyrronium and indacaterol has ...

Researchers find a 28 percent greater risk of heart attack and stroke in older patients taking commonly prescribed drugs for chronic obstructive pulmonary disease (COPD). Canadian scientists are ...

Researchers have found that dual bronchodilators -- long-lasting inhalers that relax the airways and make it easier to breathe -- do little to help people who do not have chronic obstructive pulmonary ...

OBSTRUCTIVE pulmonary emphysema, as the term is used here, refers to a chronic progressive process manifested clinically by dyspnea, which most commonly makes its appearance in middle-aged or elderly ...

January 13, 2010 (Miami, Florida) — Aerosolized bronchodilators are independently associated with an increased risk for ventilator-associated pneumonia (VAP) in critically ill patients, according to ...

Researchers supported by the National Institutes of Health have found that dual bronchodilators – long-lasting inhalers that relax the airways and make it easier to breathe – do little to help people ...

Dual bronchodilators – long-lasting inhalers that relax the airways do little to help individuals who do not have chronic obstructive pulmonary disease (COPD). Dual bronchodilators – long-lasting ...